Topic

Crysvita (burosumab)

A collection of 38 issues

How to Get Crysvita (burosumab) Covered by Aetna (CVS Health) in North Carolina: Complete PA Guide with Appeals Timeline

Answer Box: Getting Crysvita (burosumab) Covered by Aetna (CVS Health) in North Carolina Crysvita requires prior authorization from Aetna (CVS Health) for all members. To get approved, you need: genetic testing showing PHEX mutation or elevated FGF23 levels, radiographic evidence of bone disease, and a specialist prescriber experienced in metabolic

Renewing Crysvita (Burosumab) Approval with Humana in California: Timeline, Documentation, and Appeals

Answer Box: Renewing Crysvita (Burosumab) with Humana in California Fastest path to renewal: Start 60 days before your current authorization expires. Submit lab results showing serum phosphorus response, clinical notes documenting symptom improvement, and adherence records through your provider's Humana portal. If denied, file an internal appeal within

How to Get Crysvita (Burosumab) Covered by Humana in North Carolina: Prior Authorization, Appeals & Step Therapy Guide

Answer Box: Getting Crysvita Covered by Humana in North Carolina Crysvita (burosumab) requires prior authorization from Humana and step therapy through oral phosphate plus vitamin D analogs first. To get coverage in North Carolina: (1) Document failed conventional therapy with your endocrinologist, (2) Submit PA request with genetic/biochemical confirmation

How to Get Crysvita (Burosumab) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Crysvita Covered in Washington Yes, Blue Cross Blue Shield covers Crysvita (burosumab) in Washington with prior authorization. The fastest path: 1) Have your endocrinologist submit PA with genetic testing, biochemical labs (serum phosphate, FGF23), and step therapy documentation, 2) If denied, file internal appeal within 180 days,

How to Get Crysvita (Burosumab) Covered by Cigna in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Crysvita Covered by Cigna in Michigan Eligibility: Patients 6+ months with X-linked hypophosphatemia (XLH) or 2+ years with tumor-induced osteomalacia require genetic testing, specialist attestation, and documented failure of oral phosphate plus active vitamin D therapy. Fastest Path: Submit prior authorization through Cigna's provider portal

How to Get Crysvita (burosumab) Covered by Cigna in Georgia: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Crysvita (burosumab) Covered by Cigna in Georgia Eligibility: Crysvita requires prior authorization from Cigna for X-linked hypophosphatemia (XLH) or tumor-induced osteomalacia (TIO). Fastest path: Submit complete documentation including genetic testing (PHEX mutation), low serum phosphorus labs, and specialist attestation through Cigna's provider portal or Accredo

Do You Qualify for Crysvita (burosumab) Coverage by Aetna (CVS Health) in Michigan? Decision Tree & Next Steps

Quick Answer: Your Path to Coverage Yes, most Michigan patients with confirmed XLH or TIO can get Crysvita covered by Aetna (CVS Health), but prior authorization is always required. The fastest path: (1) Confirm genetic testing shows PHEX mutation or biochemical evidence of elevated FGF23 with low serum phosphorus, (2)

Do You Qualify for Crysvita (Burosumab) Coverage by Aetna CVS Health in New York? Decision Tree & Next Steps

Quick Answer: To get Crysvita (burosumab) covered by Aetna CVS Health in New York, you need genetic confirmation of XLH or biochemical proof of TIO, documented failure of conventional therapy, and submission through CVS Specialty at 1-866-814-5506. Most approvals take 30-45 days with complete documentation. If denied, file an internal

How to Get Crysvita (Burosumab) Covered by Aetna CVS Health in Florida: Complete PA Guide with Appeals Timeline

Answer Box: Getting Crysvita Approved by Aetna CVS Health in Florida Crysvita (burosumab) requires prior authorization from Aetna CVS Health. Your fastest path to approval: Submit the Aetna Crysvita precertification form with genetic testing (PHEX mutation) or elevated FGF23 levels, plus radiographic evidence of bone disease. First step today: Call

How to Get Crysvita (Burosumab) Covered by Humana in Illinois: Appeal Templates and Approval Guide

Quick Answer: Getting Crysvita (Burosumab) Approved by Humana in Illinois Prior authorization is required. Humana requires genetic confirmation of X-linked hypophosphatemia (XLH) or documented tumor-induced osteomalacia (TIO), evidence of failed conventional therapy, and specialist oversight. If denied, you have 65 days to appeal internally, then 4 months for Illinois external